Results of the Pegasus Phase 3 Randomized Trial Demonstrating Superiority of the C3 Inhibitor, Pegcetacoplan, Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Griffin, M; Hillmen, P; Szer, J; Weitz, IC; Roeth, A; Hoechsmann, B; Panse, J; Usuki, K; Kiladjian, J-J; De Castro, CM; Nishimori, H; Tan, L; Hamdani, M; Deschatelets, P; Francois, C; Grossi, F; Risitano, A; De Latour, RP

Published Date

  • April 2021

Published In

Volume / Issue

  • 193 /

Start / End Page

  • 63 - 65

Electronic International Standard Serial Number (EISSN)

  • 1365-2141

International Standard Serial Number (ISSN)

  • 0007-1048